stars 1 stars 2 stars 3

CenExel ACT (Anaheim Clinical Trials) | 116 followers on LinkedIn. Providing Unquestionable Data with World Class Customer Service | Anaheim Clinical Trials (ACT), a CenExel Center of Excellence, is dedicated to performing medical clinical trials to find new patient therapies in unique areas, including Japanese-and Chinese-bridging studies. Our Phase I Clinical Pharmacology Unit is a 30,000 SF, state-of-the-art, 90 beds, clinical research center, and features: Private patient rooms and ward setting State of the art entertainment 24-hour medical coverage, 7 days a week On-site Surgery Suite (2 Procedure Rooms, 3 Recovery Beds) Emergency Room and Intensive Care Unit located close by In the clinical trials area, ACT offers investigational therapies for indications such as Migraines, Insomnia, Chronic Pain, Osteoporosis, Hormone Replacement Therapy, Diabetes and much more. We offer new and existing therapies that manage conditions where other medical therapies may have failed.

CenExel ACT (Anaheim Clinical Trials) Questions

Sy Pretorius is the Chief Executive Officer (CEO) of CenExel ACT (Anaheim Clinical Trials).

598 people are employed at CenExel ACT (Anaheim Clinical Trials).

The NAICS codes for CenExel ACT (Anaheim Clinical Trials) are [62151, 621, 62, 6215].

The SIC codes for CenExel ACT (Anaheim Clinical Trials) are [807, 80].

Top CenExel ACT (Anaheim Clinical Trials) Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users